SCHEMBL17585904

SCHEMBL17585904

C/C=C(N)\C(=C/C)[N+](=O)[O-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16548044 1.00 — —
SCHEMBL21983782 0.80 — —
SCHEMBL10499893 0.79 — —
SCHEMBL10499910 0.79 — —
SCHEMBL6369258 0.70 — —
SCHEMBL6369262 0.70 — —
SCHEMBL10290605 0.67 — —
SCHEMBL17674104 0.65 SMN1; SMN2 (0.51) —
SCHEMBL17674106 0.65 SMN1; SMN2 (0.51) —
SCHEMBL24766912 0.64 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9527834-B2 Substituted 1-benzylquinoxalin-2(1H)-one analogs as positive allosteric modulators of muscarinic acetylcholine receptor M1 VANDERBILT UNIVERSITY (US) 2016-12-27 — — US disclosed
US-20160075690-A1 SUBSTITUTED 1-BENZYLQUINOXALIN-2(1H) ANALOGS AS POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC ACETYLCHOLINE RECEPTOR M1 NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-03-17 — — US disclosed
Send feedback